SHH and Group 3 medulloblastoma have also been generated using other approaches, including deletion of Ptch1[14] in GFAP+ cerebellar NSCs, and combined inactivation of Rb and p53 in CD133+ NSCs [15], respectively. The gene discussed is PTCH1; the disease is medulloblastoma.